ongo
battl
current
rise
viral
infecti
threat
prompt
increas
effort
develop
vaccin
technolog
major
thrust
vaccin
research
focus
develop
formul
viruslik
featur
toward
enhanc
antigen
present
immun
process
herein
facil
approach
formul
synthet
viruslik
particl
svlp
demonstr
exploit
phenomenon
protein
corona
format
induc
highenergi
surfac
synthet
nanoparticl
use
avian
coronaviru
spike
protein
model
antigen
svlp
prepar
incub
nm
gold
nanoparticl
solut
contain
optim
concentr
viral
protein
follow
remov
free
protein
antigenladen
particl
recov
show
morpholog
semblanc
natur
viral
particl
nanoparticl
track
analysi
transmiss
electron
microscopi
compar
inocul
free
protein
vaccin
svlp
show
enhanc
lymphat
antigen
deliveri
stronger
antibodi
titer
increas
splenic
tcell
respons
reduc
infectionassoci
symptom
avian
model
coronaviru
infect
comparison
commerci
whole
inactiv
viru
vaccin
also
show
evid
superior
antivir
protect
svlp
studi
demonstr
simpl
yet
robust
method
bridg
viral
antigen
synthet
nanoparticl
improv
vaccin
applic
practic
implic
manag
human
viral
infect
well
anim
agricultur
vaccin
histor
effect
countermeasur
infecti
threat
agent
resembl
pathogen
administ
mount
immun
respons
specif
target
amidst
continu
emerg
viral
threat
vaccin
technolog
continu
advanc
aim
effect
promot
antivir
immun
respons
major
develop
effort
lie
retain
integr
viruslik
featur
vaccin
formul
improv
immun
process
sever
morpholog
antigen
characterist
viral
particl
demonstr
promot
immun
potenti
exampl
particl
nanoscal
shown
better
lymphat
transport
compar
smaller
subunit
antigen
addit
display
multipl
antigen
singl
particl
facilit
effect
antigen
present
immun
cell
compar
tradit
vaccin
formul
vaccin
preserv
viruslik
featur
shown
superior
capabl
elicit
immun
respons
result
observ
also
prompt
materi
scientist
appli
synthet
nanomateri
toward
mimick
viral
featur
vaccin
develop
given
high
radii
curvatur
synthet
nanoparticl
frequent
possess
high
surfac
energi
induc
adsorpt
biomolecul
phenomenon
known
protein
corona
format
proteinrich
media
strong
nanoparticleprotein
associ
occur
spontan
mean
passiv
surfac
energi
result
particl
encas
protein
layer
dictat
particl
interact
environ
protein
corona
format
gain
increas
scientif
interest
owe
implic
biomed
applic
herein
demonstr
har
phenomenon
benefici
toward
mimick
viral
featur
vaccin
applic
show
synthet
viruslik
particl
svlp
close
semblanc
nativ
virion
physicochem
properti
antigen
display
facil
prepar
spontan
antigenparticl
associ
optim
incub
condit
use
nm
gold
nanoparticl
aunp
biolog
inert
materi
commonli
use
biomed
research
spike
glycoprotein
deriv
avian
infecti
bronchiti
viru
ibv
singlestrand
positivesens
rna
viru
belong
famili
coronavirida
control
incub
condit
prepar
spike
glycoproteinladen
svlp
fig
morpholog
featur
antigen
display
svlp
compar
nativ
ibv
viral
particl
use
nanoparticl
track
analysi
immunogold
stain
addit
vaccin
potenc
svlp
free
spike
glycoprotein
compar
avian
model
coronaviru
infect
commerci
whole
inactiv
viru
wiv
formul
current
standard
vaccin
ibv
manag
examin
parallel
coronavirus
major
viral
famili
public
exampl
includ
pathogen
behind
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
anim
ibv
prime
exampl
coronaviru
infect
respiratori
urogenit
tract
chicken
pose
seriou
econom
threat
one
import
pathogen
poultri
industri
ibv
spike
glycoprotein
form
larg
pentalshap
spike
surfac
virion
chosen
antigen
candid
implic
determin
viru
pathogen
among
coronavirus
spike
glycoprotein
possess
varieti
biolog
function
includ
trigger
cell
attach
induc
cellcel
fusion
bind
cellular
receptor
spike
glycoprotein
primari
target
ongo
vaccin
develop
effort
coronaviru
vaccin
present
studi
broad
implic
across
human
anim
diseas
manag
frugiperda
atcc
insect
cell
cultur
grace
insect
cell
medium
invitrogen
carlsbad
ca
supplement
fb
thermo
fisher
rockford
il
p
sa
antibiot
biolog
industri
beithaemek
israel
c
nm
gold
nanoparticl
aunp
solut
purchas
sigmaaldrich
st
loui
mo
avian
coronaviru
ibv
strain
propag
specificpathogenfre
spf
chicken
embryo
via
allanto
rout
previous
describ
viru
titer
ibv
determin
method
reed
muench
spf
chicken
embryo
express
embryo
infecti
dose
eid
viruscontain
allanto
fluid
concentr
purifi
use
sucros
gradient
solut
previous
describ
deriv
nativ
virion
full
spike
protein
avian
coronaviru
ibv
clone
express
use
bactobac
baculoviru
express
system
invitrogen
briefli
recombin
plasmid
construct
insert
full
spike
protein
gene
ibv
strain
access
vector
use
follow
primer
set
ibvsbamhif
ttggg
atccg
atgtt
ggtga
agtca
ibvssalif
cttgt
cgaca
ttaaa
cagac
ttttt
recombin
shuttl
vector
transpos
bacmid
e
coli
strain
recombin
bacmid
purifi
use
hipur
plasmid
midiprep
kit
invitrogen
cell
use
transfect
recombin
bacmid
recombin
baculovirus
harvest
supernat
design
recombin
spike
protein
harvest
cell
infect
multipl
infect
cell
wash
lyse
iper
insect
cell
protein
extract
reagent
thermo
fisher
recombin
protein
purifi
use
glycoprotein
isol
kit
cona
thermo
fisher
accord
manufactur
instruct
purif
protein
store
sucros
c
citratebuff
nm
gold
nanoparticl
wash
repeatedli
water
remov
citrat
stabil
result
pellet
resuspend
sucros
protein
solut
rang
concentr
mgml
mgml
purifi
spike
protein
mix
ml
gold
nanoparticl
determin
nanoparticl
track
analysi
sucros
mixtur
bath
sonic
min
follow
incub
ice
bath
min
nanoparticl
remov
unbound
spike
protein
via
centrifug
min
follow
centrifug
wash
sucros
pellet
nanoparticl
mix
pb
sonic
bath
sonic
dispers
stabil
svlp
retriev
protein
content
quantifi
use
bca
protein
assay
thermo
fisher
ml
particlesml
follow
manufactur
protocol
visual
unstabl
nanoparticl
colloid
stabl
svlp
perform
use
kv
high
resolut
transmiss
electron
microscop
fei
tecnai
particl
stabil
assess
monitor
size
svlp
day
particl
size
polydispers
index
pdi
concentr
measur
nanoparticl
track
analysi
use
nanosight
malvern
uk
concentr
particlesml
base
manufactur
instruct
particl
size
zeta
potenti
also
measur
dynam
light
scatter
use
zetas
nano
zs
concentr
particlesml
malvern
uk
base
manufactur
instruct
antigen
display
examin
use
freshli
prepar
svlp
antigen
retent
examin
mix
svlp
proteinpoor
pb
proteinrich
bsa
condit
vari
period
time
h
mark
svlp
pellet
respect
solut
particl
process
use
previous
publish
protocol
sdspage
load
buffer
protein
remov
quantif
ibv
spike
protein
elut
svlp
analyz
discontinu
sdspage
nonreduc
condit
protein
gel
transfer
onto
mm
nitrocellulos
membran
biorad
transfer
membran
soak
block
buffer
skim
milk
pb
room
temperatur
h
probe
anti
monoclon
antibodi
mab
anoth
h
three
wash
membran
incub
peroxidaseconjug
goat
antimous
igg
h
l
jackson
immunoresearch
laboratori
west
grove
pa
block
buffer
room
temperatur
h
three
wash
protein
blot
detect
either
tmb
membran
peroxidas
substrat
kpl
enhanc
chemiluminesc
ecl
substrat
pierc
band
intens
analyz
via
imag
analysi
use
imagej
presenc
ibv
spike
protein
svlp
verifi
immunogold
stain
purifi
ibv
virion
use
control
briefli
ml
svlp
virion
sampl
deposit
onto
glowdischarg
carbonco
grid
min
virion
sampl
fix
paraformaldehyd
min
wash
pb
sampl
block
bsa
min
sampl
incub
anti
mab
h
pb
wash
sampl
incub
nm
goldconjug
goat
antimous
igg
jackson
immunoresearch
laboratori
anoth
h
pb
wash
nativ
virion
stain
uranyl
acet
experi
perform
room
temper
particl
visual
kv
high
resolut
transmiss
electron
microscop
fei
tecnai
care
use
anim
approv
institut
anim
care
use
committe
nation
taiwan
univers
approv
anim
experi
carri
accord
approv
guidelin
old
balbc
mice
inject
ml
pb
free
protein
formul
svlp
contain
mg
viral
antigen
via
intrafootpad
rout
h
mice
sacrif
poplit
lymph
node
harvest
n
cryosect
mm
made
fix
min
aceton
follow
min
paraformaldehyd
section
block
normal
goat
serum
invitrogen
pb
min
stain
anti
mab
h
room
temperatur
wash
section
incub
fitcconjug
antimous
igg
jackson
immunoresearch
laboratori
h
room
temperatur
nuclei
counterstain
dapi
invitrogen
fluoresc
signal
observ
fluoresc
microscop
leica
quantifi
via
imag
analysi
use
imagej
old
balbc
mice
inject
intramuscularli
thigh
ml
formul
contain
pb
free
protein
svlp
mg
viral
antigen
mix
complet
freund
adjuv
mice
blood
collect
day
antibodi
titer
quantif
n
per
group
threeweekold
spf
chicken
obtain
jdspf
biotech
miaoli
taiwan
chicken
randomli
divid
four
differ
experiment
group
n
per
group
receiv
pb
free
protein
whole
inactiv
viru
wiv
vaccin
merial
laboratori
lyon
franc
svlp
briefli
free
protein
svlp
mg
viral
antigen
ml
emulsifi
complet
freund
adjuv
administ
via
intramuscular
rout
commerci
avail
wiv
vaccin
oilyadjuv
administ
chicken
accord
manufactur
recommend
ml
per
chick
chicken
sera
tear
collect
day
immun
postimmun
chicken
intranas
challeng
ibv
live
viru
eid
day
observ
diseas
sign
day
chicken
sacrif
day
serum
iga
igg
virusspecif
elisa
ng
purifi
ibv
virion
dilut
coat
buffer
mm
na
co
mm
nahco
ph
coat
onto
flatbottom
microtit
plate
nunc
room
temperatur
overnight
well
wash
pbst
tween
pb
three
time
block
block
reagent
skim
milk
pbst
c
h
wash
ml
chicken
serum
ad
incub
room
temperatur
h
follow
three
wash
ml
peroxidaseconjug
goat
antichicken
igi
h
l
iga
jackson
immunoresearch
block
buffer
ad
well
incub
room
temperatur
h
three
wash
ml
sureblu
reserv
tmb
microwel
peroxidas
substrat
kpl
ad
well
incub
dark
room
temperatur
min
reaction
stop
ad
ml
tmb
stop
solut
kpl
od
measur
nm
use
autom
plate
reader
thermo
fisher
total
tear
iga
quantif
elisa
perform
chicken
iga
elisa
kit
abcam
accord
manufactur
protocol
day
post
immun
chicken
spleen
minc
pass
cell
strainer
corn
obtain
singlecel
suspens
red
blood
cell
rbc
lyse
use
rbc
lysi
buffer
ebiosci
cell
resuspend
rpmi
medium
gibco
grand
island
ny
contain
fb
viabl
cell
determin
trypan
blue
stain
splenocyt
plate
ubottom
plate
corn
stimul
mg
purifi
ibv
virion
presenc
brefeldin
golgiplug
bd
bioscienc
h
c
quantif
cytokin
express
stimul
splenocyt
lyse
total
rna
isol
trizol
invitrogen
accord
manufactur
manual
realtim
rtpcr
perform
use
iscript
biorad
iq
sybr
green
supermix
kit
biorad
previous
describ
primer
chicken
ifng
gapdh
melt
curv
analysi
follow
realtim
pcr
conduct
verifi
specif
primer
set
obtain
ct
valu
normal
gapdh
rel
express
chicken
ifng
fold
chang
naiv
control
determin
method
diseas
sign
chicken
record
daili
basi
viru
challeng
clinic
score
index
ibv
infect
interpret
accord
previous
describ
method
clinic
sign
evalu
clinic
sign
lacrim
slight
shake
water
fece
tracheal
rale
lacrim
presenc
nasal
exud
depress
water
fece
appar
sneez
cough
high
degre
lacrim
nasal
exud
sever
wateri
fece
death
necropsi
gross
lesion
trachea
kidney
record
chicken
kidney
harvest
homogen
tryptos
phosphat
broth
bd
bioscienc
viral
load
kidney
assess
quantit
rtpcr
describ
viral
rna
quantif
rna
chicken
kidney
extract
use
trizol
invitrogen
accord
manufactur
manual
viral
load
assess
quantit
rtpcr
perform
iscript
biorad
iq
sybr
green
supermix
kit
biorad
use
previous
describ
primer
set
target
protein
gene
ibv
chicken
rrna
quantit
rtpcr
experi
perform
duplic
data
express
arbitrari
unit
data
analyz
anova
follow
dunnett
multipl
comparison
test
use
graphpad
prism
graphpad
softwar
san
diego
ca
p
valu
smaller
consid
signific
follow
aunp
incub
solut
differ
protein
concentr
result
nanoparticl
pellet
free
protein
redispers
sonic
pb
consist
previou
studi
nanoparticleprotein
interact
observ
higher
protein
concentr
yield
particl
increas
colloid
stabil
evidenc
disappear
discern
pellet
purpl
solut
characterist
aunp
suspens
fig
svlp
prepar
mgml
protein
suspens
readili
dispers
manifest
distinct
nonclust
nanoparticl
transmiss
electron
microscopi
fig
indic
passiv
high
particl
surfac
energi
upon
suffici
protein
coat
contrast
particl
prepar
lower
protein
content
mgml
yield
cluster
aunp
character
svlp
assess
aunp
svlp
nativ
ibv
virion
fig
use
nanoparticl
track
analysi
examin
particl
sampl
particlebyparticl
basi
via
track
scatter
laser
light
individu
particl
aunp
svlp
observ
overal
reduct
light
scatter
intens
given
aunp
known
scatter
light
extraordinari
effici
intens
reduct
svlp
attribut
success
protein
coat
restrict
light
passag
aunp
surfac
likewis
nativ
virion
lowest
light
scatter
analysi
compris
entir
organ
materi
result
demonstr
feasibl
studi
evolut
nanoparticl
protein
corona
format
use
nanoparticl
track
analysi
reveal
chang
light
scatter
size
simultan
upon
examin
size
distribut
differ
particl
svlp
show
broader
distribut
compar
sharpli
distribut
nm
aunp
protein
corona
format
increas
nanoparticl
size
nm
pdi
nm
pdi
increas
zeta
potenti
mv
mv
fig
comparison
nativ
ibv
virion
averag
diamet
nm
pdi
zeta
potenti
mv
svlp
similar
overal
physicochem
properti
examin
particl
stabil
show
svlp
remain
stabl
pb
period
size
rang
nm
pdi
nm
pdi
fig
analysi
antigen
display
freshli
prepar
svlp
show
aunp
retain
mg
spike
protein
correspond
approxim
ibv
spike
protein
per
particl
western
blot
use
analysi
reveal
sharp
protein
band
approxim
kda
fig
characterist
viral
antigen
transmiss
electron
microscopi
immunogold
stain
highlight
similar
svlp
nativ
ibv
virion
observ
immunogold
cluster
around
svlp
mirror
stain
pattern
nativ
virion
fig
observ
demonstr
close
semblanc
svlp
nativ
virion
regard
physicochem
properti
antigen
display
examin
antigen
retent
proteinpoor
pb
proteinrich
bsa
pb
condit
also
shed
light
characterist
protein
corona
around
svlp
pb
particlebound
antigen
level
remain
steadi
span
h
yield
similar
ibv
spike
protein
band
intens
across
differ
incub
sampl
fig
rapid
dropoff
particlebound
spike
protein
observ
upon
incub
bsa
immedi
retriev
svlp
bsa
solut
result
reduct
spike
protein
level
h
mark
initi
antigen
remain
svlp
observ
suggest
format
two
distinct
corona
layer
distinguish
interact
dynam
surround
biomolecul
reflect
presenc
revers
soft
corona
irrevers
hard
corona
frequent
observ
prior
nanoparticl
studi
result
indic
approxim
ibv
spike
protein
stabli
bound
svlp
protein
expect
remain
particul
form
complex
biolog
environ
upon
vivo
administr
examin
antigen
deliveri
lymphat
transport
svlp
compar
free
spike
protein
svlp
formul
administ
mice
footpad
inject
poplit
lymph
node
drain
lymph
node
footpad
subsequ
collect
section
immunofluoresc
assay
ibv
spike
proteinspecif
immunofluoresc
stain
show
significantli
enhanc
antigen
deliveri
svlp
compar
free
protein
formul
result
increas
number
fluoresc
punctat
green
lymph
node
section
fig
imag
analysi
multipl
lymph
node
section
show
svlp
formul
increas
lymphat
deliveri
approxim
fold
fig
observ
increas
deliveri
attest
strong
proteinparticl
bind
hard
corona
layer
particl
carrier
capabl
facilit
antigen
transport
vivo
enhanc
lymph
node
local
svlp
consist
prior
observ
nanoparticl
viruslik
particl
owe
nanoscal
morpholog
physicochem
properti
nanoparticl
known
facilit
free
lymphat
drainag
via
convect
transport
well
cellmedi
lymphat
deliveri
via
increas
cellular
uptak
immunogen
svlp
also
examin
follow
intramuscular
inocul
mice
antiibv
igg
serum
titer
compar
mice
vaccin
svlp
free
ibv
spike
protein
fig
observ
svlp
elicit
significantli
higher
igg
level
demonstr
improv
vaccin
potenc
free
protein
formul
improv
immunogen
explain
part
enhanc
antigen
deliveri
lymph
node
high
number
antigen
present
cell
resid
addit
particul
natur
svlp
like
also
favor
immun
activ
mechan
improv
cellular
uptak
enhanc
complement
activ
present
follicular
dendrit
cell
nanoparticlespecif
immunolog
featur
make
svlp
promis
vaccin
candid
diseas
manag
evalu
svlp
effect
viral
infect
vaccin
spf
chicken
free
ibv
spike
protein
svlp
mg
total
viral
antigen
via
intramuscular
rout
addit
refer
commerci
wiv
vaccin
ibv
administ
base
manufactur
suggest
dosag
follow
vaccin
blood
tear
collect
analysi
live
ibv
challeng
perform
fig
elisa
analysi
show
svlp
superior
gener
igg
iga
titer
compar
free
protein
formul
wiv
vaccin
fig
c
total
iga
tear
vaccin
chicken
also
quantifi
despit
intramuscular
vaccin
gener
known
nonid
promot
mucos
immun
elev
tear
iga
level
observ
three
vaccin
formul
fig
expect
mucos
vaccin
futur
studi
may
increas
tear
iga
level
better
highlight
differ
among
formul
elicit
mucos
immun
besid
humor
immun
cellular
immun
major
compon
effect
antivir
immun
respons
analyz
use
splenocyt
extract
day
svlp
sampl
show
signific
increas
ifng
mrna
level
compar
control
free
protein
wiv
vaccin
sampl
fig
demonstr
superior
promot
antigenspecif
cellular
immun
examin
effect
differ
vaccin
protect
viral
challeng
clinic
score
evalu
base
stamina
postur
voic
show
svlp
group
lowest
overal
symptom
par
anim
vaccin
wiv
formul
fig
b
comparison
vaccin
free
protein
formul
less
effect
highli
variabl
moder
diseas
symptom
day
necropsi
perform
examin
trachea
kidney
characterist
site
infect
ibv
indic
gross
lesion
photo
best
antivir
protect
observ
svlpimmun
group
wherea
organ
free
protein
group
wiv
vaccin
group
show
observ
mucu
secret
petechia
trachea
fig
upper
panel
arrow
swollen
lesion
hemorrhag
kidney
fig
lower
panel
arrow
prophylact
effect
svlp
vaccin
demonstr
examin
viral
load
kidney
analysi
quantit
rtpcr
show
immun
svlp
consist
reduc
viral
content
result
lowest
rel
viral
mrna
express
across
anim
sampl
fig
result
corrobor
protect
effect
svlp
vaccin
enhanc
humor
cellular
immun
increas
protect
viral
challeng
coronaviru
spike
protein
primari
antigen
signatur
coronavirus
contribut
characterist
crownlik
morpholog
underlin
viru
famili
protein
compris
outermost
layer
coronavirus
spike
protein
pivot
role
viral
pathogenesi
recogn
primari
target
vaccin
prepar
present
vaccin
strategi
coronavirus
includ
recombin
virus
viruslik
particl
continu
effort
develop
new
strategi
improv
vaccin
potenc
safeti
best
knowledg
incorpor
coronaviru
spike
protein
synthet
nanoparticl
previous
explor
exploit
high
surfac
energi
synthet
nanoparticl
spontan
assembl
svlp
cover
ibv
spike
protein
demonstr
strong
particleantigen
associ
result
viruss
particul
display
ibv
spike
protein
svlp
elicit
strong
immun
protect
live
ibv
challeng
enhanc
immunopotenti
particl
carrier
consist
previou
studi
echo
curiou
observ
gold
nanoparticl
promot
humor
also
cellular
immun
respons
upon
associ
antigen
increas
cellular
immun
respons
suggest
nanoparticl
may
play
role
beyond
passiv
antigen
carrier
futur
studi
examin
impact
nanomateri
nanoparticl
surfac
energi
immunolog
interact
warrant
note
phenomenon
protein
corona
format
evolv
field
studi
scientist
continu
examin
nanomateri
biolog
medium
increas
complex
subtl
chang
environ
nanoparticl
properti
dramat
unpredict
impact
overal
corona
ident
signific
biolog
implic
demonstr
practic
util
protein
corona
phenomenon
present
studi
adopt
reductionist
approach
examin
proteinparticl
interact
aunp
incub
highli
control
condit
protein
singular
speci
form
svlp
virusmimet
featur
dynam
associ
expect
vari
differ
biomolecul
nanomateri
gener
inorgan
nanoparticl
promot
stronger
protein
adsorpt
compar
organ
nanoparticl
inorgan
nanoparticl
tend
higher
surfac
energi
decreas
particl
size
also
tend
increas
biomolecul
interact
increas
radii
curvatur
nanoparticl
surfac
forc
electrostat
interact
van
der
waal
forc
coval
interact
play
intertwin
role
govern
nanobio
interfac
factor
includ
nanoparticl
function
buffer
condit
biomolecul
speci
signific
impact
corona
format
nonetheless
control
optim
condit
phenomenon
may
exploit
facil
prepar
formul
defin
characterist
favor
biolog
perform
present
work
take
advantag
spontan
interact
nanomateri
biomolecul
toward
improv
vaccin
develop
strategi
may
find
practic
applic
diseas
manag
coronavirus
well
infecti
threat
summari
demonstr
incub
viral
antigen
synthet
nanoparticl
optim
condit
spontan
format
protein
corona
induc
assembl
viruslik
nanostructur
viral
antigen
encas
particul
core
result
present
studi
valid
success
prepar
svlp
via
nanoparticl
innat
tendenc
induc
protein
coat
comparison
typic
viruslik
particl
prepar
present
strategi
offer
practic
advantag
owe
simpl
facil
process
amidst
grow
health
threat
coronaviru
infect
well
ongo
econom
impact
ibv
infect
viruslik
particl
garner
increas
scientif
interest
vaccin
candid
owe
improv
efficaci
comparison
subunit
antigen
present
studi
vaccin
svlp
result
enhanc
humor
cellular
immun
respons
improv
protect
avian
model
coronaviru
infect
compar
free
protein
antigen
commerci
wiv
vaccin
strong
immun
viral
challeng
follow
svlp
vaccin
evidenc
multipl
criteria
includ
improv
physic
symptom
reduc
organ
lesion
decreas
overal
viral
load
enhanc
immunopotenti
svlp
attribut
least
part
increas
lymphat
deliveri
multival
antigen
display
given
robust
versatil
approach
envis
techniqu
broadli
appli
differ
vaccin
develop
